Shares of Haleon PLC HLN inched up 0.97% to £3.75 Thursday, on what proved to be an all-around favorable trading session for ...
Dr. Reddy’s is focusing on a pipeline of complex drugs, including GLP-1s (such as Semaglutide) as well as biosimilars and consumer care to offset the loss of exclusivity for its blockbuster drug ...
Despite posting record revenues, pharma major Dr Reddy’s Laboratories on Thursday reported a marginal 2% increase in consolidated profit af.
The analyst's commentary reflects careful consideration of Haleon's latest guidance and market conditions, particularly the ...
In a report released today, Iain Simpson from Barclays maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...
Haleon's global business lead for the Pain Portfolio & Systemics shares key consumer health trends reshaping the healthcare ...
Haleon PLC HLN shares dropped 1.63% to £3.67 Tuesday, on what proved to be an all-around favorable trading session for the ...
In a report released today, David Hayes from Jefferies maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...
Strides Pharma Science Ltd announced that its subsidiary, Strides Pharma Global Pte. Limited in Singapore, has received USFDA ...
AdvisorNet Financial Inc reduced its stake in shares of Haleon plc (NYSE:HLN – Free Report) by 34.0% in the fourth quarter, ...
Marcum Wealth LLC raised its holdings in shares of Haleon plc (NYSE:HLN – Free Report) by 19.7% in the fourth quarter, ...
JP Morgan Cazenove and Morgan Stanley were global coordinators on the sale of a 7.7% stake in the UK consumer healthcare ...